Global Ultrasound Tumor Therapy System (HIFU) Market Growth 2025-2031

The global Ultrasound Tumor Therapy System (HIFU) market size is predicted to grow from US$ 142 million in 2025 to US$ 220 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.

Ultrasonic tumor treatment system is a high-intensity focused ultrasound HIFU device, which is mainly composed of a main unit (energy table) and a treatment bed. It mainly uses ultrasound as an energy source, and uses its penetrability and focusability to focus the external ultrasound on the lesions in the body, and directly kills the tumor tissue through instantaneous high temperature. The clinical advantages of the ultrasonic tumor treatment system are mainly that there is no surgical incision, avoiding the radiation damage of traditional radiotherapy or the systemic toxicity of chemotherapy; with micron-level precision, it can treat deep tissues.

Ultrasonic tumor treatment systems are gradually changing the traditional tumor treatment landscape with their core advantages of being non-invasive, precise (focal error ≤ 3mm) and fast recovery (1-3 days after surgery). They use high-intensity focused ultrasound (HIFU) to target and ablate lesions, avoiding surgical trauma and the toxic side effects of radiotherapy and chemotherapy. They are particularly suitable for complex scenarios such as uterine fibroids (effectiveness exceeds 95%), prostate cancer and deep bone tumors (penetration depth of more than 15cm). In terms of companies, the JC series of equipment from Chinese local manufacturer Haifu Medical leads the world; international manufacturers focus on differentiated tracks - Israel's Insightec's Exablate Neuro system has passed FDA certification and specializes in Parkinson's tremor and brain tumor treatment, and the US Sonablate's equipment accurately ablates prostate cancer through the transrectal route.

Future trends revolve around breakthroughs in three major directions: ​Intelligence​ (AI target area delineation + robot positioning), combined therapy​ (HIFU+immunotherapy activates systemic anti-tumor effects) and portability​. Although the current device penetration rate is less than 5%, with policy support and technology iteration, the global market size is expected to exceed US$200 million in 2030.

LP Information, Inc. (LPI) ' newest research report, the “Ultrasound Tumor Therapy System (HIFU) Industry Forecast” looks at past sales and reviews total world Ultrasound Tumor Therapy System (HIFU) sales in 2024, providing a comprehensive analysis by region and market sector of projected Ultrasound Tumor Therapy System (HIFU) sales for 2025 through 2031. With Ultrasound Tumor Therapy System (HIFU) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ultrasound Tumor Therapy System (HIFU) industry.

This Insight Report provides a comprehensive analysis of the global Ultrasound Tumor Therapy System (HIFU) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ultrasound Tumor Therapy System (HIFU) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ultrasound Tumor Therapy System (HIFU) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ultrasound Tumor Therapy System (HIFU) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ultrasound Tumor Therapy System (HIFU).

This report presents a comprehensive overview, market shares, and growth opportunities of Ultrasound Tumor Therapy System (HIFU) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Mobile Therapy System
Fixed Therapy System

Segmentation by Application:
Liver Cancer
Breast Cancer
Prostate Cancer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Chongqing Haifu Technology
EDAP TMS
Shenzhen PRO Hitu Medical Co., Ltd
Sonablate
Theraclion
NaviFUS
Alpinion Medical Systems
InSightec
SONIRE Therapeutics Inc
Shanghai A&S Science Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ultrasound Tumor Therapy System (HIFU) market?

What factors are driving Ultrasound Tumor Therapy System (HIFU) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ultrasound Tumor Therapy System (HIFU) market opportunities vary by end market size?

How does Ultrasound Tumor Therapy System (HIFU) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.